Related Experiment Video

Updated: Aug 14, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3

Katriina J Peltola1, Kirsi Paukku, Teija L T Aho

  • 1Turku Centre for Biotechnology, University of Turku/Abo Akademi University, Turku, Finland.

Blood
|February 7, 2004
PubMed

Insights

Pim-1 kinase inhibits Signal Transducer and Activator of Transcription 5 (STAT5) activity by stabilizing SOCS proteins, revealing a negative feedback loop in hematopoietic cell survival.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Signal transducer and activator of transcription 5 (STAT5) is crucial for cytokine-mediated survival in hematopoietic cells.
  • Pim-1, a serine/threonine kinase, is a known STAT5 target gene implicated in oncogenesis.

Purpose of the Study:

  • To investigate the role of Pim-1 in regulating STAT5-dependent transcription.
  • To elucidate the mechanism by which Pim-1 affects STAT5 activation and function.

Main Methods:

  • Ectopic expression of Pim-1 in FDCP1 myeloid cells.
  • Assessment of STAT5 tyrosine phosphorylation and DNA binding.
  • Analysis of Pim-1 interaction with SOCS1 and SOCS3 proteins.

Main Results:

  • Pim-1 expression reduced STAT5-dependent transcription in response to IL-3, prolactin, and erythropoietin.
  • Pim-1 inhibited STAT5 tyrosine phosphorylation and DNA binding, indicating interference with early activation steps.
  • Pim-1 interacted with SOCS1 and SOCS3, enhancing their inhibitory effects on STAT5, likely through phosphorylation-mediated stabilization.

Conclusions:

  • Pim-1 kinase negatively regulates STAT5 activity, independent of direct interaction.
  • Pim-1 potentiates the inhibitory function of SOCS1 and SOCS3 on STAT5.
  • Pim and SOCS proteins may form a negative feedback system to control STAT5 activity in cytokine signaling.

More Related Videos

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation09:40

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation

Published on: June 27, 2017

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...